Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications
Abstract Objective To evaluate the levels of periostin in patients with systemic sclerosis (SSc) and their association with features of systemic sclerosis. Methods The levels of periostin were assessed in the serum of 106 SSc patients and 22 healthy controls and by immunofluorescence staining in car...
Main Authors: | Fatima El-Adili, Justin K. Lui, Mortada Najem, Giuseppina Farina, Maria Trojanowska, Flora Sam, Andreea M. Bujor |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-022-02943-2 |
Similar Items
-
Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications
by: Fatima El-Adili, et al.
Published: (2023-01-01) -
Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects
by: Andreea M. Bujor, et al.
Published: (2020-05-01) -
Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study
by: Giacomo De Luca, et al.
Published: (2024-01-01) -
The role of periostin in kidney diseases
by: Agnieszka Turczyn, et al.
Published: (2021-11-01) -
Periostin as a modulator of chronic cardiac remodeling after myocardial infarction
by: Marcos F. Minicucci, et al.
Published: (2013-10-01)